Capital Mãe

计划入组 446 人

Amplatzer™Amulet™ Post-Market Study (Amulet™PMS)

计划入组 1,088 人 · 首次发布于 2015 年 5 月 18 日

CAPITAL OFFLOAD-SHOCK

计划入组 456 人 · 首次发布于 2026 年 8 月 11 日

trimethylangelicin (Rare Partners)

DLL3(Molecular Partners)

177Lu/225Ac labeled alphavbeta3-integrin targeting peptidomimetics (Advanced Innovative Partners)

Proximity Capital Partners, LLC

United States

HAMILTON CAPITAL PARTNERS INC CANADIAN EQTY YIELD MAXIMIZE CLASS E ETF

United States

Hercules Capital

United States

Alliance Clinical Network and Atlas Clinical Research Merge to Form National Clinical Trial Platform

Abbott's Amplatzer Amulet Shows Long-Term Benefits in AFib Stroke Prevention

Bluebird Bio Goes Private in $29M Deal with Carlyle and SK Capital Partners